Close Menu

Meridian Bioscience

Bioline, a Meridian Bioscience company, this week launched the EPIK Quantification and EPIK Amplification kits.

Sygnis said this week that Qiagen has launched the first two products of a series of kits based on Sygnis' proprietary SensiPhi amplification technology.

NEW YORK (GenomeWeb News) — Meridian Bioscience today reported a 1 percent year-over-year drop in fiscal 2014 first-quarter revenues with mixed results in both its Illumigene molecular diagnostics and core life science businesses.

Meridian Bioscience today reported $44.8 million in preliminary revenue for its fiscal first quarter, marking a 1 percent decline from the year-ago period. Preliminary revenues included $34.8 million in sales from its Diagnostic segment, a 2 percent decline from fiscal Q1 2013.

NEW YORK (GenomeWeb News) - Meridian Bioscience today reported $44.8 million in preliminary revenue for its fiscal first quarter, marking a 1 percent decline from the year-ago period and falling short of consensus analyst estimates of $49 million.

Scientists from UK-based molecular diagnostics developer Lumora have published a pilot study demonstrating how a new heat elution-based sample prep method can be combined with isothermal amplification and Lumora's bioluminescent assay in real-time (BART) readout technology to qui

RainDance Technologies this week announced it has added a high-precision chromosomal copy number variation measurement application to its RainDrop Digital PCR system.

NEW YORK (GenomeWeb News) — Meridian Bioscience today reported a 13 percent year-over-year increase in fiscal fourth quarter revenues and a 9 percent spike in full-year fiscal 2013 revenues.

NEW YORK (GenomeWeb News) – Meridian Bioscience today initiated sales and earnings guidance for its Fiscal Year 2014, while it reiterated prior guidance for full-year fiscal 2013.

NEW YORK (GenomeWeb News) – Meridian Bioscience said today that sales in its fiscal third quarter rose 12 percent year over year.

Pages

An international commission is to develop a report on how researchers, clinicians, and regulators should evaluate the clinical applications of human germline genome editing.

The American Prospect writes that the pilot program to test the DNA of migrants could lead to more family separations.

The US Department of Agriculture presents a new blueprint for animal genomic research.

In Genome Research this week: repetitive element deletion linked to altered methylation and more in form of muscular dystrophy; human contamination in draft bacterial and archaeal genomes; and more.